Loading...
Header Logo
Keywords
Last Name
Institution

Mayra Tisminetzky

Concepts (111)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
11
2017
713
3.290
Why?
Acute Coronary Syndrome
3
2017
171
1.640
Why?
Hospitalization
7
2017
639
1.360
Why?
Electrocardiography
2
2015
287
1.230
Why?
Angiotensin-Converting Enzyme Inhibitors
3
2017
114
1.000
Why?
Hospital Mortality
6
2015
525
0.990
Why?
Patient Readmission
3
2015
154
0.930
Why?
Survivors
1
2017
80
0.800
Why?
Adrenergic beta-Antagonists
2
2017
123
0.800
Why?
Cognitive Therapy
2
2012
88
0.660
Why?
Myocardial Revascularization
1
2014
62
0.640
Why?
Secondary Prevention
1
2014
93
0.630
Why?
Diabetes Mellitus
2
2015
391
0.630
Why?
Forecasting
1
2014
164
0.620
Why?
Diabetes Complications
1
2014
94
0.620
Why?
Primary Prevention
1
2014
94
0.610
Why?
Treatment Outcome
8
2017
2500
0.590
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
146
0.580
Why?
Platelet Aggregation Inhibitors
1
2014
223
0.560
Why?
Length of Stay
5
2017
396
0.550
Why?
Massachusetts
9
2015
1503
0.530
Why?
Time Factors
7
2017
2528
0.530
Why?
Anxiety
1
2012
146
0.510
Why?
Middle Aged
12
2017
9555
0.510
Why?
Anxiety Disorders
1
2011
69
0.510
Why?
Retrospective Studies
7
2017
2360
0.510
Why?
Male
17
2017
16706
0.500
Why?
Aged
12
2017
7323
0.490
Why?
Female
17
2017
18128
0.480
Why?
Depressive Disorder, Major
1
2011
140
0.470
Why?
Patient Discharge
4
2017
201
0.430
Why?
Risk Factors
7
2017
2908
0.420
Why?
Depression
1
2012
384
0.410
Why?
Heart Failure
4
2017
425
0.400
Why?
Follow-Up Studies
4
2015
1490
0.400
Why?
Age Factors
4
2015
1079
0.390
Why?
Multivariate Analysis
3
2017
691
0.370
Why?
Aged, 80 and over
7
2017
2720
0.360
Why?
Humans
17
2017
33173
0.350
Why?
Survival Rate
3
2015
462
0.350
Why?
Prognosis
4
2015
852
0.340
Why?
Cohort Studies
4
2017
1331
0.330
Why?
Coronary Artery Bypass
2
2015
245
0.300
Why?
Sex Factors
3
2015
649
0.290
Why?
Chi-Square Distribution
3
2017
339
0.270
Why?
Adaptation, Psychological
2
2012
156
0.250
Why?
Disease-Free Survival
1
2017
99
0.210
Why?
Renal Insufficiency, Chronic
1
2017
38
0.200
Why?
Lung Diseases
1
2017
81
0.200
Why?
Diuretics
1
2015
31
0.180
Why?
Risk Assessment
3
2015
1026
0.180
Why?
Calcium Channel Blockers
1
2015
68
0.180
Why?
Longitudinal Studies
1
2017
692
0.180
Why?
Health Status
1
2017
311
0.170
Why?
Stroke Volume
1
2015
188
0.170
Why?
Quality of Life
1
2017
425
0.160
Why?
Academic Medical Centers
1
2015
170
0.160
Why?
Adult
4
2017
9343
0.150
Why?
Personality Inventory
2
2011
55
0.150
Why?
Aspirin
1
2014
160
0.150
Why?
Predictive Value of Tests
1
2015
649
0.150
Why?
Comorbidity
2
2015
701
0.140
Why?
Cooperative Behavior
1
2013
140
0.140
Why?
Case-Control Studies
1
2014
621
0.140
Why?
Models, Psychological
1
2012
91
0.140
Why?
Incidence
1
2014
755
0.140
Why?
Severity of Illness Index
1
2015
807
0.140
Why?
Pediatrics
1
2013
170
0.140
Why?
Psychiatric Status Rating Scales
1
2012
310
0.130
Why?
Fear
1
2011
34
0.130
Why?
Mental Health Services
1
2013
179
0.130
Why?
Angina, Unstable
1
2011
68
0.130
Why?
Health Services Accessibility
1
2013
282
0.130
Why?
Body Mass Index
1
2014
726
0.120
Why?
Outcome and Process Assessment (Health Care)
1
2010
180
0.110
Why?
Inpatients
1
2010
142
0.110
Why?
United States
1
2017
3863
0.110
Why?
Cross-Sectional Studies
1
2011
1183
0.100
Why?
Monoamine Oxidase Inhibitors
1
2002
9
0.080
Why?
Antidepressive Agents, Tricyclic
1
2002
16
0.080
Why?
Fluoxetine
1
2002
38
0.070
Why?
Odds Ratio
2
2015
578
0.070
Why?
Acute Disease
2
2015
512
0.070
Why?
Antidepressive Agents
1
2002
141
0.070
Why?
Depressive Disorder
1
2002
187
0.070
Why?
Logistic Models
2
2015
845
0.060
Why?
Cardiotonic Agents
1
2015
35
0.050
Why?
Urban Health
1
2015
43
0.050
Why?
Shock, Cardiogenic
1
2015
44
0.050
Why?
Chronic Disease
1
2017
533
0.040
Why?
Checklist
1
2013
25
0.040
Why?
Geriatric Assessment
1
2013
82
0.040
Why?
Confidence Intervals
1
2013
236
0.040
Why?
Survival Analysis
1
2013
365
0.040
Why?
Proportional Hazards Models
1
2013
441
0.040
Why?
Analysis of Variance
1
2013
535
0.030
Why?
Guideline Adherence
1
2013
218
0.030
Why?
Mass Screening
1
2013
286
0.030
Why?
Edema
1
2010
27
0.030
Why?
Practice Guidelines as Topic
1
2013
428
0.030
Why?
Chest Pain
1
2010
34
0.030
Why?
Dyspnea
1
2010
45
0.030
Why?
Adolescent
2
2013
3958
0.030
Why?
Health Care Surveys
1
2010
232
0.030
Why?
Cough
1
2010
120
0.030
Why?
Prospective Studies
1
2013
1580
0.030
Why?
Child
1
2013
2614
0.020
Why?
Double-Blind Method
1
2002
458
0.020
Why?
Postmenopause
1
2002
222
0.020
Why?
Randomized Controlled Trials as Topic
1
2002
313
0.020
Why?
Dose-Response Relationship, Drug
1
2002
694
0.020
Why?
Tisminetzky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_